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Abstract:  A  fiber-optic  system  was  developed  to  rapidly  acquire  tissue 
fluorescence wavelength-time matrices (WTMs) with high signal-to-noise 
ratio  (SNR).  The  essential  system  components  (473  nm  microchip  laser 
operating at 3 kHz repetition frequency, fiber-probe assemblies, emission 
monochromator, photomultiplier tube, and digitizer) were assembled into a 
compact  and  clinically-compatible  unit.  Data  were  acquired  from 
fluorescence  standards  and  tissue-simulating  phantoms  to  test  system 
performance. Fluorescence decay waveforms with SNR > 100 at the decay 
curve peak were obtained in less than 30 ms. With optimized data transfer 
and monochromator stepping functions, it should be feasible to acquire a 
full WTM at 5 nm emission wavelength intervals over a 200 nm range in 
under 2 seconds. 
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1. Introduction 
The multidimensional data provided by fluorescence spectroscopy opens up the possibility of 
rapidly  deriving  quantitative  diagnostic  information  from  tissues  in  a  minimally-invasive 
manner [1]. Steady-state and time-resolved fluorescence measurements have been performed 
with  instrumentation  designed  for  eventual  translation  to  the  clinic  [2–4].  Steady-state 
fluorescence spectroscopy has been employed for cancer diagnostics in organs including the 
breast  [5],  cervix  [6],  esophagus  [7,8],  lung  [9],  and  pancreas  [10–12].  Time-resolved 
fluorescence spectroscopy has been employed for cancer diagnostics in organs including the 
brain [13,14], colon [15,16], esophagus [8], and lung [17]. Steady-state and time-resolved 
fluorescence measurements have been employed in ophthalmology for detection of conditions 
including  macular  degeneration,  diabetic  retinopathy,  and  retinal  artery  occlusion  [18,19]. 
Time-resolved fluorescence measurements have also recently been used for the detection of 
cardiovascular disease [20] and type 2 diabetes [21]. 
Although  steady-state  fluorescence  can  reveal  information  about  fluorophores  in  a 
biological tissue, the intensity of steady-state spectra are influenced by a variety of artifacts 
[3]. Time-resolved fluorescence measurements provide the fluorescence lifetime τ, which is 
the mean time spent by a fluorophore in its excited state [22]. The lifetime value is sensitive 
to the environment of the fluorophore, so it can vary with changes in binding, pH, oxygen, 
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based  effects  such  as  absorption,  photobleaching,  and  changes  in  excitation  intensity  and 
collection efficiency [3,23]. Lifetime values for multiple fluorophores in a sample can be 
obtained from time-resolved fluorescence measurements, even if the steady-state spectra of 
the fluorophores overlap. Therefore, steady-state and time-resolved methods are both useful 
tools for characterization of biological tissue fluorescence. 
Ideally one would maximize the amount of independent fluorescence information and the 
quality of the data (signal-to-noise ratio, for example) for every sample. However, clinical 
applications require consideration of measurement speed, portability, cost, and ease of use. 
The  first  in  vivo  endoscopic  time-resolved  fluorescence  measurements  on  human  patients 
were reported in 1998, using a portable, fiber-optic based system with a low repetition-rate 
laser and limited spectral resolution [15,16]. Since then, two strategies have been employed 
for combining spectral and temporal fluorescence data collection in a clinically compatible 
format.  The  first  approach  uses  one  laser  excitation  source,  but  two  different  detection 
platforms. The spectral and temporal data are collected in sequence, but could be obtained 
simultaneously.  The  second  approach  collects  a  full  fluorescence  wavelength-time  matrix 
(WTM, Fig. 1) by stepping an emission monochromator through a series of wavelengths, such 
that  a  fluorescence  decay  curve  is  produced  sequentially  at  each  of  those  wavelengths. 
Integrating the WTM over time yields a steady-state fluorescence spectrum. Integrating the 
WTM over wavelength yields a time-resolved fluorescence decay curve. 
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Fig.  1.  Fluorescence  wavelength-time  matrix  (WTM)  of  1  µM  Rhodamine  6G  in  ethanol 
acquired with fiber-optic probes for light delivery and detection. The WTM contains both 
wavelength-resolved and time-resolved fluorescence data. 
In this study, a specialized compact digitizer was employed to obtain WTMs from samples 
excited with a microchip laser, which had a repetition rate significantly higher than that used 
in similar spectroscopic devices [8,14,15,20]. Section 2 describes the technology developed 
for  detecting  fluorescence  WTMs,  the  incorporation  of  this  technology  into  a  clinically 
compatible fiber-probe based instrument, and the experimental methods employed to assess 
the  technology.  Section  3  details  system  characterization  using  standard  fluorophore 
solutions. Section 4 describes using the system to acquire fluorescence WTMs from tissue-
simulating phantoms. 
2. Instrumentation and experimental methods 
2.1 Clinically-compatible instrumentation 
The instrumentation (Fig. 2) consisted of a 473 nm microchip laser (Lumanova, 20-030005, 
µFlare Blue, 3 kHz pulse repetition rate, ~2 ns pulse duration), a specialized transient digitizer 
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scanning  monochromator  (Optometrics,  MC1-03),  and  a  photo-multiplier  tube  (PMT) 
(Hamamatsu, H6780-20). 
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Fig.  2.  Schematic  of  the  instrumentation  developed  for  rapid  acquisition  of  fluorescence 
WTMs, using fiber-optic probes for light delivery and detection (set-up 4, Table 1). WTMs 
were also obtained with three other set-ups (Table 1): (1) right-angle free-space geometry, in 
place of the fiber-probes, for light delivery and detection; (2) free-space light delivery and a 
fiber-probe for fluorescence detection; (3) a fiber-probe for light delivery and right-angle free-
space geometry for detection. 
The  FI  digitizer  is  an  extremely  compact,  low  power  digitizer  for  direct  waveform 
recording of the  fluorescence decay curves. Its  unique 10-bit, fast-in slow-out, analog-to-
digital converter operates at 1 gigasample/second (GS/s) with a sampling depth of 128 ns. For 
most applications, 5X interleaving is applied to increase the effective sampling rate to 5 GS/s. 
This approach permits high-speed sampling without requiring equally high-speed conversion, 
which enables  very reliable  digitization. Event rates in excess of 25 kHz are possible. A 
graphical user interface enables user control over input parameters. 
The digitizer can be employed to measure single-laser pulse collections. Additional laser 
pulses  can  be  averaged  to  increase  the  signal-to-noise  ratio.  The  time  increase  for 
measurements with additional laser pulses averaged is proportional to the increased number of 
laser pulses, with a small increase in pulses averaged not greatly affecting total collection time 
due to the rapid acquisition speed and high repetition rate laser employed. For samples with a 
lower concentration of fluorophores and weaker fluorescence signal, the PMT voltage can be 
increased prior to measurement to maximize the dynamic range of the digitizer. The detection 
system has a wavelength resolution of 0.01 nm and a temporal resolution of 200 ps. 
The dimensions of the main system components are: 16 cm x 10.3 cm x 3.0 cm (digitizer), 
9.5 cm x 4.0 cm x 7.0 cm (microchip laser), 15.2 cm x 6.4 cm x 6.4 cm (monochromator), 5.1 
cm x 2.6 cm x 2.6 cm (PMT), 19.5 cm x 5 cm x 10 cm (laser power supply), and 16.5 cm x 
10.5 cm x 4.5 cm (pulse generator). This small table-top footprint makes the system ideal for 
eventual translation to a clinical setting. 
2.2 Optical configurations (fiber optics vs. free space) 
For system characterization, four different system set-ups (Table 1) were employed to acquire 
WTMs from standard fluorophore solutions. Set-up 1 was a free-space right-angle geometry 
commonly used for cuvette-based measurements. Set-ups 2 and 3 were identical to set-up 1, 
except that set-up 2 used a fiber for detection and set-up 3 used a fiber for light delivery. Set-
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Industries, SFS600/660N, 600 µm core diameter) for light delivery and detection. For the 
reported studies, fiber-optic probes were inserted vertically 1 cm below the top surface of the 
fluorophore solution and 3 cm above the bottom of the cuvette with a 660 µm probe spacing. 
Table 1. Set-ups employed to acquire fluorescence WTMs 
Set-up  Light delivery  Fluorescence detection 
1  Direct illumination  Right-angle detection 
2  Direct illumination  Fiber-optic probe 
3  Fiber-optic probe  Right-angle detection 
4  Fiber-optic probe  Fiber-optic probe 
Focusing  lenses  (Thorlabs,  LA4306-UV,  LA4052-UV)  and  a  500  nm  longpass  filter 
(Semrock, FF01-488) were employed in set-ups 2 and 4 to couple and filter light from the 
fiber-optic  probe  to  the  monochromator.  In  set-up  4,  fiber  holders  were  attached  to 
micrometer stages for controlled source-detector spacing. 
2.3 Sample preparation 
2.3.1 Standard fluorophore solutions 
The system performance was tested (Section 3) by acquiring WTMs from solutions of three 
standard fluorophores: rhodamine 6G (Sigma, R4127), fluorescein (Sigma, 166308), and rose 
bengal (Sigma, 330000). Each fluorophore was made with a 1 µM concentration in ethanol. 
The  solutions  were  thoroughly  mixed  in  a  cuvette  prior  to  measurement.  Signal-to-noise 
characterization of the system was performed with a stock solution (~1.7 × 10
7 beads/mL) of 
fluorescent beads (Invitrogen, A7303). 
2.3.2 Tissue-simulating phantoms 
Four  tissue-simulating  phantoms  were  made  with  different  scattering  coefficients.  Each 
phantom originated from a ~1 mM solution of Rhodamine B (Sigma, R6626) in deionized 
water. For the first phantom, 4 mL of deionized water was combined with 4 µL of the original 
Rhodamine B solution. For the second phantom, 3.5 mL of deionized water was combined 
with 0.5 mL polystyrene microspheres (Duke Standards, 4009A, 1µm diameter) before adding 
4 µL of the Rhodamine B solution. For the third phantom, 3 mL of deionized water was 
combined with 1 mL of polystyrene microspheres before adding 4 µL of the Rhodamine B 
solution. The fourth phantom was made by combining 2 mL of deionized water with 2 mL of 
the polystyrene microspheres before adding 4 µL of the Rhodamine B solution. Thus, the 
resulting concentration of Rhodamine B in each mixture was 1 µM. Each of these mixtures 
was then thoroughly combined with ~0.025 g of powder gelatin (Sigma, 097K0108) in a 50 
mL conical tube. Then, each mixture was transferred to a 35 mm Petri dish and placed on an 
80°C hot plate for 20 minutes to dissolve the gelatin, stirring every 5 minutes. Each sample 
was removed from the hot plate and returned to room temperature before refrigeration at 3°C 
overnight to solidify the sample. The resulting thickness of each phantom was ~4 mm. 
An integrating sphere (RT-060-SF, Labsphere, North Sutton, NH) set-up was employed to 
measure  the  scattering  coefficient  for  each  phantom  [27].  Briefly,  a  lamp  with  a  Kohler 
illuminator  (KI-120,  Labsphere)  was  connected  to  a  power  supply  (LPS-150-0660, 
Labsphere) to uniformly illuminate each phantom. Two configurations, one for reflectance 
and  one  for  transmittance,  were  used;  in  both  cases,  the  detected  light  traveled  from  the 
integrating sphere into a spectrometer (Ocean Optics, Dunedin, FL, HR2000 + ) via an optical 
fiber  (Ocean  Optics,  P1000-2-VIS-NIR).  The  wavelength-resolved  reflectance  and 
transmittance of each phantom were input into an inverse adding-doubling (IAD) algorithm 
[28]  to obtain  the  absorption  and  scattering  coefficients.  For  the  four  phantoms,  three  of 
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and scattering coefficients of 10 cm
−1, 50 cm
−1, 108 cm
−1, and 222 cm
−1. 
3. System characterization - reference fluorophores in fluid solution 
3.1. Signal-to-noise as function of acquisition time 
A stock solution of fluorescent beads was used to measure the signal-to-noise ratio of the 
system as a function of laser pulses averaged per waveform (Fig. 3). Fluorescence decays 
were collected at 550 nm only and the standard deviation of fluorescence intensity from ten 
measurements  was  calculated  by  averaging  standard  deviations  of  intensity  around  the 
emission decay maximum (t = 36–38 ns). In Fig. 3(a), the standard deviations (green curve) 
were  measured  with  system  set-up  4  (Fig.  2)  and  were  obtained  for  acquisition  times 
corresponding to 5, 125, 250, 375, 500, 750, 1000, 1250, and 1500 laser pulses averaged. The 
result was characteristic of Poisson noise (blue curve), which was defined as the square root 
of mean intensity divided by the square root of the number of laser pulses averaged, and 
multiplied by a factor of 0.045 to match the scale of the experimental results. The arrow in 
Fig. 3(a) represents fluorescence acquisition with 125 laser pulses averaged. This fluorescence 
detection had a peak intensity of ~28 (a.u.) and a standard deviation of ~0.25 (a.u.), yielding a 
SNR greater than 100. 
Figure 3(b) shows two measurements of time-resolved fluorescence: one obtained with 5 
laser pulses (red curve), and the other obtained with 1250 pulses (purple curve). These two 
curves correspond to the circled collection points in Fig. 5(a). The two curves were similar in 
shape despite a 250-fold decrease in the number of laser pulses averaged. 
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Fig.  3.  Signal-to-noise  characterization  of  the  system,  performed  on  a  stock  solution  of 
fluorescent beads: (a) standard deviation of measured fluorescence intensity (green curve), 
compared to prediction of Poisson theory (blue curve), as a function of acquisition time; (b) 
normalized fluorescence decay curves for 5 laser pulses averaged (red curve, corresponding to 
red circle in (a)) and 1250 laser pulses averaged (purple curve, corresponding to purple circle 
in (a)). The arrow in (a) denotes data acquisition with 125 laser pulses averaged; the standard 
deviation of the relative peak intensity at this point is ~0.25 (a.u.) with a peak signal intensity 
of ~28 (a.u.), yielding a SNR greater than 100. 
3.2 Wavelength-resolved fluorescence 
WTMs were acquired from the standard fluorophore solutions from 500 to 650 nm in steps of 
2 nm, using 1250 laser pulses for excitation per wavelength. Time-resolved fluorescence was 
acquired from 0 to 127.8 ns in steps of 0.2 ns. The PMT setting was varied to keep detected 
signal  within  the  operating  range  of  the  digitizer.  Prior  to  data  acquisition,  the  emission 
intensity  of  each  sample  was  monitored  for  one  minute  to  verify  that  no  photobleaching 
occurred. 
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solution. For each  fluorophore, three  measurements  with the  fiber-based  set-up (set-up 4,  
Fig.  2)  were  averaged  to  obtain  the  spectra  shown  in  Fig.  4.  The  error  bars  (standard 
deviation)  were  similar  in  size  for  all  four  of  the  system  set-ups  (data  not  shown).  The 
collection time for each WTM was 82 seconds. The wavelength range measured was 500 to 
650 nm with a 2 nm step size. For each wavelength, 1250 laser pulses were averaged to 
produce  the  time-resolved  decay.  These  data  were  in  good  qualitative  agreement  (peak 
intensity wavelength agreed within 2 nm) with those reported in the literature [29]. 
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Fig.  4.  Fluorescence  spectra  of  rhodamine  6G  (blue  curve),  rose  bengal  (red  curve),  and 
fluorescein (green curve), measured with the fiber-based system set-up 4 and normalized to the 
area under the curve. Each curve is the average of three measurements; the error bars represent 
the standard deviation. 
3.3 Time-resolved fluorescence and extraction of fluorescence lifetimes 
Figure 5 shows time-resolved fluorescence decay curves obtained with the four system set-
ups for rhodamine 6G [Fig. 5(a)], rose bengal [Fig. 5(b)], and fluorescein [Fig. 5(c)]. Each 
plot represents the average of the time-resolved fluorescence decays acquired for four set-ups 
(Fig.  2)  and  multiple  emission  wavelengths.  For  each  of  these  three  plots,  time-resolved 
measurements at the peak emission wavelength as well as wavelengths corresponding to 0.6x 
peak  intensity  were  averaged.  Time-resolved  fluorescence  was  obtained  at  three  different 
emission wavelengths for rhodamine 6G and rose bengal. Time-resolved fluorescence from 
fluorescein was obtained at only two different emission wavelengths because the emission 
peak of fluorescein was near the first collection wavelength. The time-resolved fluorescence 
decays  for  each  set-up  were  shifted  to  a  common  peak  value  for  comparison,  because 
integrating  fiber-optic  probes  into  the  system  set-ups  changed  the  travel  time  slightly  for 
delivered laser pulses and detected fluorescence. The error bars plot the standard deviation for 
each  fluorophore,  indicating  that  the  measured  time-resolved  decays  are  consistent  across 
collection wavelengths and system set-up geometries. 
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Fig. 5. Time-resolved fluorescence decay curves measured on solutions of rhodamine 6G ((a), 
(d)), rose bengal ((b), (e)), and fluorescein ((c), (f)). Panel (a) plots 36 averaged rhodamine 6G 
fluorescence decays, panel (b) plots 36 averaged rose bengal fluorescence decays, and panel (c) 
plots 24 averaged fluorescein fluorescence decays (four system set-ups per fluorophore, three 
emission  wavelengths  for  rhodamine  6G  and  rose  bengal,  two  emission  wavelengths  for 
fluorescein).  The  error  bars  represent  standard  deviation.  In  panels  (d),  (e),  and  (f),  one 
representative decay curve for each fluorophore measured with set-up 4 was fit to a single 
exponential decay. 
Figure 5 also shows  fits of  representative time-resolved fluorescence curves  measured 
with  set-up  4  from  rhodamine  6G  [Fig.  5(d)],  rose  bengal  [Fig.  5(e)],  and  fluorescein  
[Fig. 5(f)] to a single-exponential decay e
-t/τ, where τ is the mean fluorophore lifetime. An 
iterative  least-squares  fitting  algorithm  was  employed  to  obtain  these  fits  and  extract  the 
corresponding lifetime values [25]. In order to perform the fitting procedure, the instrument 
response function (IRF) was also acquired for each detection setting. The IRF was measured 
from a sample of deionized water in a cuvette, using neutral density filters to reduce the 
transmitted light energy to the sample. All data was fit using an IRF taken within 1 nm of the 
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the fit data and repeatable across experiments. The residuals are presented to show the quality 
of each fit. 
Lifetime analysis was performed on the four set-ups at the peak fluorescence wavelength 
from each fluorophore, as presented in Table 2. All data was fit as a single exponential decay 
with Fluorescence Analysis Fitting Software (Fluorescence Innovations (FI), Inc., Bozeman, 
MT). The extracted lifetimes were in good agreement with previously reported values and this 
agreement was consistent for each set-up. For each system set-up, three measurements were 
collected for each fluorophore and independently fit. The reported lifetime is the average of 
the three measurements plus or minus the standard deviation. 
We note that the small discrepancies between lifetimes extracted for the four set-ups, as 
well as between the measured and literature values, could be due to differences in the way that 
the  IRF  was  acquired,  external  factors  such  as  temperature  and  pH,  or  impurities  in  the 
fluorophore  solutions.  For  the  measurements  reported  here,  each  fluorophore  was  used 
directly  from  the  manufacturer  without  further  purification,  and  temperature  and  pH 
conditions were not monitored. 
Table 2. Lifetime values obtained from standard fluorophore solutions 
      Measured 
a    Literature 
      Set-up 1    Set-up 2    Set-up 3    Set-up 4     
Emission 
Wavelength  
(nm) 
Fluorophore    Lifetime  
(ns)    Lifetime  
(ns) 
  Lifetime  
(ns)    Lifetime  
(ns)    Lifetime  
(ns) 
550  Rhodamine  
6G    3.977 ± 
0.001    3.828 ± 
0.004 
  3.971 ± 
0.004    3.910 ± 
0.001    3.99 ±  
0.01 [30] 
514  Fluorescein    4.449 ± 
0.004    4.603 ± 
0.007 
  4.534 ± 
0.002    4.620 ± 
0.004    4.25 ±  
0.01 [30] 
572  Rose 
Bengal    0.668 ± 
0.014    0.676 ± 
0.006 
  0.648 ± 
0.003    0.711 ± 
0.001    0.850 ±  
0.030 [22] 
aFor each system set-up, three measurements were independently fit. The reported lifetimes are average plus or 
minus the standard deviation of these three fits. 
4. Tissue-simulating phantom study 
System  set-up  4  (Fig.  2)  was  employed  to  acquire  WTMs  from  four  tissue-simulating 
phantoms with different scattering coefficients in a range relevant to biological tissue. The 
measured scattering coefficients of the tissue-simulating phantoms (Section 2.3.2) were 10 
cm
−1, 50 cm
−1, 108 cm
−1, and 222 cm
−1. A 0.66 mm fiber-probe source-detector separation 
was used during WTM collection for each phantom. Additional measurements with fiber-
probe  source-detector  separations  of  1.66  mm,  2.66  mm,  3.66  mm,  and  4.66  mm  were 
collected for the tissue-simulating phantoms with a scattering coefficient of 108 cm
−1 and 222 
cm
−1. Data was acquired from 500 to 700 nm (in 5 nm steps) with 1250 laser pulses averaged 
per wavelength. For tissue simulating phantoms with higher scattering coefficients, the PMT 
high-voltage was decreased for WTM measurement. The data acquisition time for each tissue-
simulating phantom (see Section 5.2.1) was 49 seconds. As discussed in Section 5, this time 
can be substantially reduced with straightforward modifications, by decreasing the number of 
laser pulses averaged, or increasing the step size. 
Figure 6(a) shows steady-state fluorescence spectra for each phantom, averaged over three 
sites and normalized to the area under the curve. Each of these spectra is a combination of the 
fluorescence spectra of gelatin (dark red curve) and Rhodamine B (dark green curve). The 
spectra of the four phantoms are very similar, with some small variations around 515 nm and 
575 nm, where the standard deviations (error bars) are also higher. These variations may be 
the result of a variable gelatin fluorescence signal in the phantoms. Figure 6(b) plots time-
resolved fluorescence decay curves obtained from averaging measurements at peak intensity 
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decays at all three sites are similar. 
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Fig.  6.  Wavelength-resolved  (a)  and  time-resolved  (b)  fluorescence  from  tissue-simulating 
phantoms with varying scattering coefficients (measured with a source detector separation of 
0.66 mm). Three sites on each phantom were measured. The spectra represent the average of 
the three sites, with error bars representing standard deviation. Panel (a) also includes spectra 
from pure gelatin and from a solution of rhodamine B in deionized water. 
Figure  6(b)  suggests  that  phantoms  with  increased  scattering  coefficients  exhibited 
stretched  waveform  decay.  The  stretched  waveform  decay  shown  in  Fig.  6(b)  for  tissue-
simulating phantoms with a µs of 108 cm
−1 and 222 cm
−1 (using a fiber-probe source-detector 
separation of 660 µm) was also observed for larger source detector separations out to 4.66 
mm (data not shown). The distortion of the waveform was observed for each source-detector 
separation  measured,  with  the  relative  waveform  differences  between  each  phantom 
remaining  the  same.  For  the  4.66  mm  source-detector  separation,  at  which  the  diffusion 
approximation is valid, the experimentally observed trend matched the prediction of diffusion 
theory (Fig. 7) [1]. In Fig. 7, the experimental results and the diffusion theory predictions 
were both time-shifted to align the rising shoulders of the decay curves for the two different 
scattering coefficients (108 cm
−1 and 222 cm
−1). Additionally, both diffusion theory results 
were  convolved  with  the  corresponding  instrument  response  functions  from  the  phantom 
measurements.  Computational  studies  employing  Monte  Carlo  codes  to  model  photon 
propagation  are  underway  to  further  investigate  the  effect  of  increased  optical  scattering 
coefficients on the resulting transient fluorescence decay and extracted fluorophore lifetime 
[16,31,32]. 
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Fig.  7.  Measured  time-resolved  fluorescence  decay  curves  from  two  phantoms  with 
biologically-relevant scattering coefficients at a source-detector separation of 4.66 mm (a), 
compared with the predictions of diffusion theory (b). Each curve in (b) is a convolution of the 
diffusion  theory  result  with  the  instrument  response  function  of  the  corresponding  tissue-
simulating phantom. For the sake of comparison, the experimental results and the diffusion 
theory predictions were time-shifted to align the rising shoulders of the curves. In both panels, 
the time-resolved decay from the medium with the higher scattering coefficient (red dashed 
curve)  was  noticeably  broader  than  the  decay  from  the  medium  with the  lower  scattering 
coefficient (blue solid curve). 
5. Discussion 
Most clinical  fluorescence instruments emphasize the spectral domain, often  integrating a 
spectrograph  and  CCD  camera  for  rapid  data  collection  in  which  the  entire  spectrum  is 
measured  at  once.  In  these  systems,  data  is  acquired  over  multiple  laser  shots  for  signal 
averaging. Most approaches for acquiring time-resolved fluorescence employ a pulsed laser 
and digital oscilloscope. The nitrogen laser is often employed because it is small, relatively 
low cost, and its UV wavelength (337 nm) excites endogenous fluorescence. However, the 
effectiveness  of  the  nitrogen  laser  for  rapid  collection  of  time-resolved  fluorescence  is 
hindered by its relative low pulse repetition frequency. 
In  this  report,  we  employed  a  473  nm  microchip  laser  (3  kHz  repetition  rate)  and  a 
specialized digitizer capable of collecting the data obtained at this rate. The system was tested 
on standard fluorophore solutions and tissue-simulating phantoms. WTMs from samples with 
fluorophore concentrations of 1 µM were acquired with speed (under 25 s for a WTM from 
500 to 650 nm with a 5 nm step size and 125 laser pulses averaged) and precision (error less 
than  1%  for  Rhodamine  6G  and  Fluorescein  solutions),  without  maximizing  the  sensing 
capabilities of the transient digitizer. 
The  autofluorescence  intensity  measured  from  biological  tissues  depends  on  several 
factors, including the excitation wavelength, fiber-probe geometry, and composition of the 
biological sample. It is likely that detected autofluorescence signals from biological tissues 
will  be  weaker  than  those  from  the  stock  fluorescent  solutions  used  in  this  study.  To 
compensate for this signal loss, system parameters can be changed to increase the detected 
fluorescence intensity. For example, the excitation fiber diameter can be increased in size to 
excite a larger sample volume and the detection fiber diameter can be increased to detect a 
larger portion of the emitted fluorescence photons. In addition, the PMT gain can be increased 
in order to maximize the dynamic measurement range of the digitizer. 
We note that the stretched behavior of the fluorescence decay curves from phantoms with 
increased scattering coefficients is under investigation. Preliminary results suggest that the 
Rhodamine B lifetime in the phantom is different than its value in cuvette solution, which 
may be due to the dependence of the fluorescence properties of Rhodamine B on its local 
environment [30]. Specifically, the lifetime of Rhodamine B within the phantoms may have 
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phantoms containing a more stable fluorophore (Rhodamine 6G [30]). 
It is important to note that the system set-ups reported here were designed only for point 
measurements,  not  imaging.  However,  the  system  can  be  modified  to  perform  scans  of 
multiple  points  on  a  sample  in  order  to  generate  spatially-resolved  information.  Spatial 
resolution  can  also  be  obtained  by  use  of  fiber-probes  with  multiple  source-detector 
separations. 
It is also important to note that the acquisition speed of this system is not fully optimized. 
Acquisition time depends on laser pulse repetition frequency, number of laser pulses averaged 
per waveform, and spectral resolution. In addition, there is the time overhead associated with 
moving from one wavelength to the next and downloading an averaged waveform. Much of 
the time needed to generate the WTM data presented in this report was consumed by data 
transfer to a computer and stepping of the monochromator. The actual time it takes for the 
stepper motor to advance to the next wavelength once the command has been received and 
recognized is very small. Likewise, the data transfer time is very fast once the computer is 
alerted  that  data  is  ready  for  transfer  and  the  computer  communicates  that  it  is  ready  to 
receive this data. Additional delays are caused by having the computer update the graphical 
display after each waveform. 
Currently,  waveform  averaging  is  performed  on  the  digitizer  and,  one  at  a  time,  the 
averaged waveforms are downloaded. However, the digitizer can store up to 4000 waveforms 
before its memory is full. If 100 laser pulses were averaged per waveform (including the 5X 
interleaving), the data associated with 40 such waveforms (corresponding to the wavelength 
range from 500 nm to 695 nm in steps of 5 nm) could be packed in memory. For a laser pulse 
repetition rate of 4000 Hz, the 100 pulses necessary per waveform are generated every 25 ms. 
The  monochromator  could  be  independently  controlled  to  step  every  25  ms  without  any 
intermediate  communication  once  the  sequence  is  initiated.  In  this  scenario,  the  operator 
could hit a keystroke (or depress a foot pedal) to start the acquisition, then after a brief delay 
the full WTM would be collected in one second. Data transfer from the digitizer memory to 
the computer would take a few additional seconds, after which the system would be ready to 
repeat the process. The actual waveform averaging could then be performed on the computer, 
post data collection. 
6. Conclusions 
In this paper, we reported on the design and validation of novel technology for rapid, precise, 
and accurate acquisition of fluorescence wavelength-time matrices (WTMs) from fluorophore 
solutions and tissue-simulating phantoms. The clinically compatible technology employs a 
microchip laser with a 3 kHz repetition rate and a digitizer capable of detecting at this rate. 
The system can rapidly acquire fluorescence WTMs with high signal-to-noise ratio (greater 
than  100  when  averaging  125  laser  pulses  per  emission  wavelength).  The  compact  size 
enables future system translation to a portable, clinically-compatible unit. Integrated fiber-
optic probes to deliver excitation light and detect fluorescence emission provide the capability 
for remote sensing of fluorescence from biological tissues. 
These  results  suggest  that  the  system  will  be  able  to  perform  rapid  and  accurate 
measurements of time- and wavelength-resolved fluorescence in a biomedical environment. 
The accurate, rapid, and portable nature of the system, combined with the information-rich 
fluorescence data set supplied by WTM collection, suggest that the technology reported here 
is potentially useful for a number of biomedical optics applications in clinical settings. 
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